Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · IEX Real-Time Price · USD
5.00
-0.63 (-11.19%)
At close: May 17, 2024, 4:00 PM
5.01
+0.01 (0.20%)
After-hours: May 17, 2024, 7:59 PM EDT

Treace Medical Concepts Revenue

Treace Medical Concepts had revenue of $196.03M in the twelve months ending March 31, 2024, with 26.48% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $51.11M with 21.12% year-over-year growth. In the year 2023, Treace Medical Concepts had annual revenue of $187.12M with 31.92% growth.

Revenue (ttm)
$196.03M
Revenue Growth
+26.48%
P/S Ratio
1.59
Revenue / Employee
$379,905
Employees
516
Market Cap
311.27M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023187.12M45.28M31.92%
Dec 31, 2022141.84M47.42M50.22%
Dec 31, 202194.42M37.05M64.59%
Dec 31, 202057.37M17.95M45.54%
Dec 31, 201939.42M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cerus 191.72M
Zynex 188.68M
biote 187.32M
Pulmonx 72.99M
Precigen 5.44M
Revenue Rankings